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bias favoring the publication of positive results (Schlaepfer and 
Fins, 2010). Finally, DBS in psychiatry raises additional ethical 
questions because its mechanism of action is not yet clear, even 
for movement disorders (Benabid et al., 2005; Kringelbach et al., 
2007), the hypotheses being either synaptic inhibition or depolari-
zation blockade (Dostrovsky et al., 2000; Perlmutter et al., 2002; 
Vitek, 2002).
In the first section this paper examines media coverage of 
surgical brain therapies for psychiatric disorders, in particular 
prefrontal leukotomy. In the second section, it explores cur-
rent, enthusiastic media portrayals of DBS, and how these might 
encourage a false assumption that all ethical issues have been fully 
discussed. In the third section, it addresses the primary sources 
of DBS information used by science journalists and the roles 
of scientific experts, peer-reviewed journals and the media in 
evaluating and shaping ethical issues raised by the development 
and expansion of DBS. In particular it suggests embracing a novel 
strategy to produce ethical consensus about controversial issues 
such as DBS.
Lessons from the past
Deep brain stimulation is not the first surgical treatment for psy-
chiatric disorders to be depicted in the popular media. Between 
1935 and 1960, in Europe and the United States, prefrontal leu-
kotomy (widely called “lobotomy” in journalistic accounts) was 
accepted uncritically by a large part of the scientific community. 
Consequently it was presented by the media as a “miracle cure” for 
IntroductIon
As a treatment for psychiatric disorders, neurosurgical 
 interventions, such as prefrontal leukotomy, were performed 
in the mid-twentieth century on many tens of thousands of 
patients (Gostin, 1980, 1982; Mashour et al., 2005). This thera-
peutic approach, later called “psychosurgery,” was hailed by the 
media enthusiastically, despite a lack of scientific evidence of 
its effectiveness and without an evaluation of the ethical issues 
involved. Medical research is propelled, in part, by public needs 
and sometimes by public expectation. Researchers have an inter-
est in promoting their research also in the popular press, and this 
can stimulate public interest in new therapies without adequate 
information. This is particularly troubling in the case of the new 
neuromedical discoveries with deep ethical implications.
The current experimental expansion of deep brain stimulation 
(DBS) applications, from the control of motor disorders to psy-
chiatric conditions (Bell et al., 2009; Clausen, 2010; Schlaepfer and 
Fins, 2010) raises the legitimate worry that DBS treatments might 
also gain popularity in the media before a full evaluation of issues 
related to ethics and effectiveness is undertaken. This worry can, 
in part, be motivated by three factors. First, although distinct from 
classic psychosurgery (Synofzik and Schlaepfer, 2008; Schlaepfer 
et al., 2010), DBS is an invasive treatment that can generate sev-
eral postoperative complications and side effects, such as cognitive, 
behavioral, psychiatric, and psychosocial impairments (Clausen, 
2010). Second, the ethical discourse is often ignored in the scientific 
literature (Bell et al., 2010), which is characterized by a selection 
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disruptive behaviors. In 1949, the Nobel Prize for Physiology or 
Medicine was awarded to the Portuguese neurologist Egas Moniz, 
“for his discovery of the therapeutic value of leukotomy in certain 
psychoses” (Nobel Foundation, 1949). This prestigious prize dem-
onstrated the wide acceptance by the scientific community at the 
time, and most probably encouraged the public to see prefrontal 
leukotomy as a safe procedure.
In their paper on the portrayal of lobotomy in the American 
popular press, Diefenbach et al. (1999) concluded that the 
acceptance of lobotomy benefited from optimistic media cov-
erage, especially in the 1930s and 1940s. It was proposed that 
unbalanced popular press coverage was an important factor in 
stimulating interest in lobotomy: “It was generally known that 
many patients were referred […] as a result of all the publicity” 
wrote Valenstein (1986) in his history of psychosurgery. Walter 
Freeman, an American physician who had strong relationships 
with journalists from widely read newspapers and magazines, 
played an important role in advertising the procedure (El-Hai, 
2005). Diefenbach et al. (1999) described how competition 
between media professional to break dramatic stories combined 
with fame-seeking by representatives of the medical community 
(or with research interests in some fields) created a relationship 
which served both the media and the physicians, but not neces-
sarily the public interest.
In a study on psychosurgery in Sweden between 1944 and 
1958, Ogren noted that pioneering early experiments of pre-
frontal lobotomy, performed by neurosurgeons in collabora-
tion with psychiatrists in Stockholm in 1944, were followed by a 
rapid implementation of the new surgical approach (Ogren et al., 
2000). In 1946 and 1947, the two state mental hospitals, Umedalen 
and Sidsjön, introduced prefrontal lobotomy on a large scale. 
Prefrontal lobotomy was characterized, in certain city hospitals, 
by an initially high rate of postoperative mortality that reached 
more than 15%. Nonetheless, in a comparative media study Ogren 
found that most of the articles on lobotomy in the Swedish and 
American media were positive or neutral toward psychosurgery, 
whilst negative articles were less frequent. Neutral articles were 
more common in Swedish media (43%) whilst less common in 
American media (19%). Articles that were highly negative toward 
lobotomy were more often found in the American press (32%) 
than in the Swedish (14%). This difference was due to the lack, in 
the Swedish society of the time, of a small but strong opposition 
to this procedure that was present in the American scientific com-
munity. There was also a tradition of investigative journalism that 
pushed some American writers to examine patients’ postoperative 
outcomes (Ogren, 2007).
More balanced reports started to appear in American press in 
1945, in parallel with the appearance of scientific studies that quan-
tified dramatic side effects associated with the therapy. Following 
this more balanced reporting, the use of the procedure declined. 
This was also, in part, due to the introduction of chlorpromazine, 
the first drug for mental illness, which raised new hopes for psy-
chiatric patients (Pressman, 1998).
Low-income patients with low-educational attainment were the 
first victims of media enthusiasm for lobotomy (Valenstein, 1986). 
Part of the explanation was the higher burden of psychiatric illness 
for patients and families in a poor social environment.
It is important to recognize that contemporary public percep-
tions of the efficacy of DBS in psychiatric disorders may parallel 
earlier enthusiasm for surgical interventions in psychiatry, since 
the media had already made a connection between psychosurgeries 
and DBS (Fins, 2003).
overLy optImIstIc medIa portrayaL and negLect of 
ethIcs
Past and present DBS media reports, without or with only a pass-
ing attention to ethics, offer fertile ground for hype in both sci-
entific journals and the popular press. For example, following the 
publication of “Memory Enhancement Induced by Hypothalamic/
Fornix Deep Brain Stimulation” (Hamani et al., 2008), there was a 
wave of positive reporting concerning the use of DBS for memory 
enhancement, with a particular focus on Alzheimer’s patients, 
without scrutiny of either the vulnerable nature of these patients 
or the merely accidental or serendipitous nature of this discov-
ery (initially the study was conducted to treat severe obesity). 
For instance, the scientifically respected and influential Nature 
announced the findings in an optimistic news article entitled 
“Brain electrodes can improve learning” (Abbott, 2008) and sug-
gested the possible application for people with Alzheimer’s disease 
without any concern for the ethics related to this population of 
patients. This enthusiastic media shock wave was instantly rep-
licated on an international scale. Indeed, BBC News popularized 
the same results by publishing an article positively entitled “Deep 
stimulation ‘boosts memory’” (Coombes, 2008), while articles 
appeared in The Telegraph and The Independent titled respectively 
“Discovery could make Alzheimer’s a memory” (Clout, 2008) and 
“Scientists discover way to reverse loss of memory” (Laurence, 
2008). None of these articles discussed or mentioned the oppor-
tunity of using DBS for memory enhancement in a vulnerable 
population such as Alzheimer’s patients, although they all referred 
to this neurodegenerative disorder as a pathology potentially 
treatable with DBS.
By praising medical and scientific innovation without paying 
attention to ethical issues, the media risk to turn ethical neglect 
into de facto ethical approval, thereby promoting public accept-
ance of DBS. Other important questions raised by DBS applica-
tions (i.e., criteria for the selection of patients, acute, and chronic 
side effects, DBS use in pediatrics, benefits to patients, and quality 
of life) are absent in popular media, also due to the fact that they 
are not properly discussed in scientific literature (Clausen, 2010; 
Racine et al., 2010).
Regrettably, this type of optimistic coverage of DBS is not 
only limited to mass media. As Schlaepfer and Fins (2010) report, 
several DBS single-case studies have been published which high-
light the secondary effects of research (such as memory enhance-
ment) even when the primary goals (such as treating obesity) 
have not been achieved; as was the case in the Hamani et al. 
(2008) paper, referred to earlier. Even if selective publishing bias 
is not unique to research on DBS (Chien, 2004; Nature Neurosci, 
2004; Lau et al., 2008; Schlaepfer and Fins, 2010), by focusing 
on the positive outcomes of DBS, both the scientific literature 
and the popular media neglect common ethical issues (risk–ben-
efit ratio, informed consent, inclusion–exclusion, side effects, 
patient’s autonomy, etc.).
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ethIcaL debate and medIa constraInts
When analyzing media coverage of DBS, it is important to exam-
ine the process of selection of what becomes “news,” and evaluate 
the primary sources of information on this topic: peer-reviewed 
publications and experts. This is confirmed by a study by Racine 
et al. (2010) which reports that 42% of the quotations about DBS 
published in articles in the popular press come from a scientist 
with a public sector affiliation and 14% come from physicians and 
other healthcare providers.
The role of science journalism, especially in covering ethical 
topics, has been discussed in depth in recent years. In a recent 
Nature editorial “Science Journalism, too close for comfort,” 
Boyce Rensberger, past director of the Knight Science Journalism 
Fellowship program at the Massachusetts Institute of Technology, 
argued that science journalists need to stay as close as possible to 
the researchers producing science, but still need to keep a healthy 
distance. Tracing a brief history of the evolution of science journal-
ism in the Internet era – from the role of “cheerleaders” of scientists 
to the role of “watchdog” – he affirms that: “If science journalists are 
to regain relevance to society […] they must learn enough science 
to analyze and interpret the findings – including the motives of the 
funders. And, as if that were not enough, they must also anticipate 
the social impacts of potential new technologies while there is still 
time to make a difference” (Rensberger, 2009).
Anticipating the social impacts of promising new DBS therapies 
obviously requires a discussion about ethics. Such discussion is just 
starting in the scientific community, and with some reluctance: 
“Neuroscientists have reasons for their reluctance to wade into 
ethics. The questions raised are likely to be open-ended, and their 
arrival in the world outside the laboratory may be some way off” 
stated a Nature Editorial (2006) entitled “Neuroethics Needed,” 
which focused in particular on functional MRI. Now, how can 
science journalists identify and discuss, in a meaningful and satis-
factory way, the ethical issues raised by a new DBS therapy when 
even the experts in the field and the scientific literature tend not 
to discuss them?
The answer is not easy, and lies at least in part in the search for 
new ways of cooperation, particularly between the scientific com-
munity and the media, which face these kinds of difficulties, not 
only when dealing with DBS and neuroscience, but throughout the 
whole spectrum of issues related to research and health. A recent 
statement published under the auspices of the International Society 
of Pharmacovigilance, for instance, highlighted the importance of 
such an approach: “New ways to cooperate with the media as profes-
sional equals must be explored to help the provision of balanced, 
comprehensible, trustworthy, and interesting safety information to 
the public on a regular basis, apart from specific announcements 
or reports of problems or crises” (Erice Statement, 2010).
Media are expected to play an informative and argumentative 
role – in particular, to conduct wide debate of social issues regarding 
DBS. In the current over-optimistic portrayal, media typically do 
not question the assumptions under which the medical literature 
reports DBS results. Ethics may be difficult to implement when 
dominant scientific news is based on DBS efficacy rather that safety. 
In addition, promises of a cure – with or without exaggeration, are 
useful to attract public attention in a news world in which every 
article needs to compete in order to be noticed. The issue, well 
In a seminal study, Racine et al. (2007) reviewed 235 articles on 
neurostimulation techniques in the print news media in the U.K. 
and the U.S. They reported that 51% were optimistic depictions, 
whilst only 4% emphasized the risks. Among the articles reviewed, 
29% contained a “personal twist,” including first person narratives 
and descriptions of “miracle stories of patients cured of Parkinson’s 
disease, dystonia, and Tourette’s syndrome” (Racine et al., 2010). 
Diem et al. (1996) and Schneiderman (2005) have pointed out that 
patients educate themselves and build their hopes from uncritical 
sources, such as television and the internet. In that sense, the media 
have an influential place in patient education, comprehension, and 
understanding of health issues.
From the point of view of the lay reader or potential psychiatric 
patient who goes through an informed consent process, the use 
of an easily optimistic depiction – both in the medical literature 
and in the popular media – can be far more influential than some 
of the austere and subtle explanations found in specialized ethics 
journals. Bell et al. (2009), in an insightful study using health-
care providers, report that enthusiastic media portrayals of DBS 
influence patients’ hopes and expectations. They concluded that 
healthcare providers view media portrayals of DBS as “playing a 
key role in establishing expectations for DBS patients and for the 
public in general.” Media portrayals of DBS can lead to a false 
assumption that ethical issues have been discussed which affects 
patients’ expectations.
Ford (2009) suggests that overly optimistic reports about 
new neurosurgical innovations generate an “educational vulner-
ability” for patients. He affirms that very often when patients 
consider neurosurgical techniques they have already been pre-
conditioned by overly optimistic portrayals of novel brain inter-
ventions, and this compromises informed consent. This is similar 
to what Bell et al. (2009) report in their study of healthcare 
provider perspectives.
Even if DBS is both scientifically valid and reasonably safe, 
patients’ lack of appreciation of the risks and the potential con-
sequences of the procedure raises significant ethical challenges. 
Moreover, whilst potential DBS patients may be legally competent, 
they may not be able to make meaningfully autonomous deci-
sions regarding their participation in any proposed DBS treat-
ment. This is not only because of the burden of their own illness, 
but also a consequence of the impression created by enthusiastic 
media accounts often coupled with the non-neutral attitude of 
the surgeon. Given the lack of common official ethical guidelines 
for patient selection in DBS trials amongst countries, it is difficult 
to prevent unethical applications of this technique on competent 
but fragile subjects.
Informed consent is an important mechanism for respecting 
patient autonomy, but in order to reach this ambitious goal, the 
effect of exposure to unbalanced media reports must also be consid-
ered. DBS providers have the responsibility of designing a process 
for obtaining a fully informed consent, while avoiding the exploita-
tion of unrealistic hopes. Addressing the lack of awareness of the 
ethical and social challenges of DBS is a duty and a responsibility 
not only of the popular media. Most of the neurosurgical literature 
focuses mainly on technical details and only superficially addresses 
fundamental questions about patient selection and inclusion cri-
teria, informed consent and resource allocation.
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noted in the first section, this happened in the past with other 
surgical treatments for behavioral disorders that have a heavy 
social impact. In the absence of public debate on the complex 
ethical aspects of the widespread use of DBS, enthusiastic media 
accounts might result in an unjustified promotion of these thera-
pies (Schlaepfer and Fins, 2010). The need for more responsible 
reporting, both from popular media and from neuroscientists 
and neurosurgeons, calls not only for better research on this topic 
but also for the promotion of initiatives favoring a multidirec-
tional model of discussion among all parties – science experts, 
the public and the media. This amounts to a “cultural” shift 
that openly acknowledges and rewards public outreach, whilst 
supporting the development of neuroscience communication 
experts, as well as empirical research into neuroscience com-
munication (Racine et al., 2010).
In an environment in which the media are not expected (and 
often not prepared) to raise the ethical issues which remain 
unaddressed by the scientific community, the challenge is to 
rethink and reinvent communication strategies to improve the 
role of the media. This improved role requires the members of 
the press to act as watchdogs of science and to highlight the 
gap often existing between the goals of science and the needs of 
society. This goal could be achieved by promoting continuing 
education and training within the journalistic profession, with 
the help of the scientific community, which should start con-
sidering journalists as “professional equals” (Erice Statement, 
2010). In order to achieve more effective communication by 
researchers, and to help journalists in their background research 
on ethical issues related to science, a number of approaches have 
proved effective. These include: free access for journalists to 
medical literature databases and official sources of information, 
peer review within the profession and science media centers 
designed to put scientists in touch with journalists in a context 
promoting cooperation and reciprocal trust (Schwitzer, 2008; 
Editorial Lancet, 2009; Kirby, 2011).
In a case-study published on Science Communication, Smith 
et al. (2010) evaluate the impact that a cancer media center had 
on the quality of cancer news in the United States. They conclude 
that in order to spread the use of good preventive practices, provid-
ing the community of journalists and the general audience with 
good informative materials about cancer prevention is not enough, 
and has to be coupled with the search for a “clear articulation of 
shared goals.”
The search for an alliance between all the stakeholders charac-
terizes the experience of the British Science Media Centre (SMC). 
According to its director Fox (2009), combining the provision of 
good information materials with the organization of regular meet-
ings and debates between the media and the science community 
improved the quality of reporting, especially on issues related to 
ethics. This goal was achieved by putting a great effort in helping 
specialized reporters: “[…] The support we give to specialist cor-
respondents has undoubtedly helped to strengthen their hand by 
ensuring that they get the best science stories in advance of non-
specialists in the newsroom. The SMC has continued to champion 
specialist reporters both within the scientific community and in all 
our dealings with news editors. It is our strong view that they are 
the best allies of science in the media […]” (p. 125).
known inside the journalistic profession, is reflected in a recent 
headline in the British Medical Journal: “Health Journalism: two 
clicks away from Britney Spears?” (Coombes, 2009).
Although a variety of critiques have been leveled at mass media 
portrayals of DBS (Racine et al., 2007; Ford, 2009), it is very dif-
ficult to create a context in which such portrayals can be questioned 
by all parties – the media, science experts, and the public. Several 
experts in neuroethics have stressed the importance of a novel 
approach, capable of moving from the current widespread top-
down approach – from the scientists to the general public through 
the “translation” by the media – to a multidirectional model of 
discussion that encourages open dialog and the mutual enrichment 
of all parties. In particular, Racine et al. (2009) argue that: “Such 
a scheme recognizes both that science is part of culture and that 
societies are increasingly multicultural. The distinction between 
expert and lay conceptions becomes a continuum, in which each 
interacts with the other. Given calls for increased public dialog, 
sustained relationships with the media and growing interdiscipli-
nary dialog with colleagues in the humanities and social science 
are also needed. This scheme will also enable public advocacy for 
neuroscience […] and will firmly situate science communication 
within a robust framework.”
Public deliberation has already been used in several contexts 
related to health and ethics. It was adopted, for instance, to explore 
public concerns and desires about the development of biobanks 
(O’Doherty and Burgess, 2009) and the adoption of new health 
technologies (Milewa, 2006). Applying this logic to the commu-
nication of neuroscience research, Illes et al. (2010) focus on the 
need for scientists to listen to the public and the public’s interest in 
learning about science, in order to promote an approach capable 
of reflecting “the values of trust, reciprocity and transparency by 
engaging non-experts and acknowledging that they have a right to 
be involved in the conduct of science.” Illes et al. (2010) note, how-
ever, that this “calls for enhanced training of neuroscientists and a 
willingness to engage in less conventional approaches. Empirical 
research throughout the process of public engagement is an integral 
part of this training.”
dIscussIon
By presenting exclusively positive data, the media tend to describe 
and explain DBS outcomes without reference to ethical debates. 
Despite the immature state of DBS as a treatment for psychiatric 
conditions, patients rely on information about DBS from media 
portrayals. This may encourage the use of DBS as a treatment for 
more and more psychiatric conditions in which there are good 
theoretical grounds justifying the surgery but the evidence is still 
weak and preliminary. The ethical issues related to DBS are usually 
debated by scientists and experts only after specific concerns have 
been raised, as it happened in Canada after the discovery of the 
potential effects of DBS on memory (Hamani et al., 2008). What 
was presented as a possible treatment that could be offered to all 
patients has become the subject of a study by Laxton et al. (2010) 
on six Alzheimer’s patients which in phase 1 proved the safety of 
the procedure and is currently evaluating its long-term efficacy.
Unbalanced media reports can convey to the general public, 
and to potential patients, the idea that DBS represents a default 
option for the treatment of all refractory psychiatric diseases. As 
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